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Objective: This study was designed to determine the frequency of Candida in clinically diagnosed cases of 
onychomycosis.  
Materials and Methods: This cross-sectional study was conducted in the Department of Microbiology, BMSI, 
JPMC, Karachi A total of 328 clinical samples have been collected. The fungal isolates were identified according to 
standard microbiological procedures. Samples were processed for primary screening microscopic test by KOH 
20% (potassium hydroxide solution) wet mount. Processing for mycological culture was done by using 
Sabouraud's dextrose agar (cycloheximide and chloramphenicol), without antibiotics and Dermatophytes test 
mediumResults: Prevalence of fungal species that isolated from the 328 samples, 14.33% were dermatophytes, 
6.40% were non-dermatophytes mould, 23.70% were Candida, 4.87% were mixed growth and 50.30% were 
negative for growth. Among the 16 mixed isolates, 15 were Candida species, accounting for a total of 28.4% 
Candida isolates. Conclusion: A significant number of onychomycosis cases result from the Candida spp. and 
Candida albicans were the main species. However, Candida non-albicans species are emerging in onychomycosis. 
In this manner, a legitimate conclusion of the pathogens of onychomycosis is vital for focused treatment. 
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Introduction 
 
Onychomycoses are the infections of a nail; it is a 
global dermatological problem with different 
frequencies and relapses are increasing in the young 
population in the past few decades.1 It could be a 
critical open wellbeing issue since of its high 
recurrence of the event, related morbidity, and long-
lasting treatment.2 It is frequently persistent, 
troublesome to abolish, contains a propensity to 
reappear, and needs systemic antifungal treatment.3 
Onychomycosis may lead to nail deformation which 
causes job and cosmetic-related issues.4,5 Moreover, 
untreated patients can be a foundation of disease for 
family members and presumably debases public 
regions as it is contagious and transmitted by direct 
contact or contaminated utensils.6 
Formerly, only dermatophytes were considered the 
most frequent pathogen of onychomycosis, and 
Trichophyton species were the most common7 whereas 
non-dermatophyte moulds were infrequent.8 Scenario 
is shifting from dermatophytes to Candida9 and it is 
established that Candida species are causing 
onychomycosis.5,8,10 Over the years, candidal 
onychomycosis was only considered with hand 
paronychia but now it is recognized that Candida 
species cause nail disorders identical to 
dermatophytes.8,11,12 Candidal onychomycosis (CO) 
influences fingernails in individuals who work in a 
muggy and wet environment or regularly douse their 
hands in water. The CO may represent in one of four 
ways: candidal paronychia, chronic mucocutaneous 
candidiasis, secondary candidiasis, total dystrophic 
onychomycosis.8 Candidal paronychia is the most 
predominant form of CO.8  
In Candida >200 species are included, Candida albicans 
is mostly associated with onychomycosis12 followed by 
C. parapsilosis.13 Despite it other species are rising such 
as C. utilis and C. lipolytica.14 The prevalence of Candida 
species is ranging between 3.5% to 58.5% 11,15 and in 
some literature, it is reported up to 71.4%, in 
onychomycosis.16 The epidemiology of Candida species 
varies in the geographic region and some species are 
intrinsically resistant to some antifungal agents. This 
will result in failure of treatment and recurrence of the 
onychomycosis. This needs the continuous monitoring 
of Candida species spectrum in the local region. In 
Pakistan, most of the laboratories only perform direct 
microscopy and the culture facilities are limited. 
Therefore the present research was designed for the 
assessment of the prevalence of Candida species in the 
local population. 
Materials and Methods 
 
A cross-sectional study was conducted in the 
Department of Microbiology, Basic Medical Sciences 
Institute (BMSI), Jinnah Postgraduate Medical Centre 
(JPMC), Karachi with the collaboration of the 
Dermatology Department, JPMC, Karachi. The 
duration of this research was one year.  
Sample size:  
A total of 328 nail specimens were collected. The 
sample size was calculated by Open Epi online 
software using reference study 4.  
Inclusion criteria: 
 All the clinically suspected cases of onychomycosis 
were included irrespective of age and gender.  
Exclusion criteria:   
Exclusion criteria were patients having lesions other 
than onychomycosis, and antifungal drugs were 
excluded. 
Ethical Consideration: 
The ethical approval was obtained from the 
Institutional Review Board (IRB) of JPMC, Karachi 
(Reference No: F.2-81/2018-GENL/2928/JPMC), and 
informed consent was obtained from all participants.  
Sample collection and processing:  
Nail samples were collected in accordance with the 
standard method from the affected area of the nail. 
Aseptically small fragments of nail clippings, scraping 
of the nail bed and subungual debris were collected on 
a filter paper and labeled with patient primary data for 
sample identification. The direct microscopy was 
performed as KOH (20%) wet mount 17. For culture 
specimen was inoculated on Sabouraud’s dextrose 
agar (SDA, [Oxoid UK]) with and without antibiotics 
and Dermatophytes test medium (DTM, [Oxoid UK]) 
vials.  Inoculated vials were incubated at 25ºC and 
37ºC accordingly. The fungal species were identified 
by colonial and microscopic characteristics. 
Microscopic features of isolates were observed by 
using lactophenol cotton blue stain (LPCB). Candida 
species were identified by the API 20C AUX Candida 




For the data analysis, IBM-SPSS version 23.0 was used 
for appropriate variables. The prevalence of fungal 
isolates in 328 nail samples, 47 (14.33%) were 
dermatophytes, 21 (6.40%) other mold, 78 (23.70%) 
Candida, 16 (4.87%) were mixed growth, and the 
remaining 166 (50.30%) samples were negative for 
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growth. The overall 162 (49.33%) samples were 
positive for fungal isolates. 
 
Figure 1: Distribution of fungal isolates in 
onychomycosis (n=328) 
 
Among the all fungal isolates, 93 (28.3%) were 
Candida species, out of that 78 (83.87%) were in pure 
form, as a single pathogen and 15 (18.17) as mixed 
growth with other fungal pathogens. Among the 
candidial species, C. albicans was the most prominent 
49 (52.68%) and followed by the Candida non-albicans 
(Table 1). 
 
Table 1: Prevalence of Candida species in 
onychomycosis (n=93) 
Candida species Number (%) 
  
Candida albicans 49(52.68%) 
Candida tropicalis 25(26.88%) 
Candida parapsilosis 11(11.82%) 
Candida glabrata 4(4.30%) 
Candida guilliermondii 1(1.07%) 
Candida krusei 2(2.15%) 





Nail infections are reported around the world and 
onychomycoses account for about 30% of all 
superficial diseases and 50% of nail infections.18 It 
impedes the quality of life, cumbersomeness, and 
other mental consequences, in addition to torment and 
misfortune of ability.10 The predominance of 
onychomycosis is changing completely different 
topographical zones. In the present study, the 
prevalence was 49.39% and the previous studies from 
different countries reported as 36.9%, 56.8%, 58.41%, 
and 76% from Chile, India, Iran, and Bangladesh 
respectively.9,11,18,19 Previously from Pakistan low 
prevalence was reported by Ahmed et al.4 but in 2016, 
it was increased from 20% to 42% 20 and in the present 
study, it was 49.39%. This may be due to small sample 
size, lack of awareness about onychomycosis, and/or 
there is a gradual increase in prevalence.  
The pathogenic spectrum of onychomycosis is changed 
and dermatophytes are overcome by Candida 
species.15 Presently, it has been reported that there is 
an increase in predominance of candidal 
onychomycosis due to extend presentation to damp 
work, different injuries from exposure to physical and 
chemical work.10 The similar pattern was observed in 
the present work, as Candida was the more prevalent 
in onychomycosis, followed by dermatophytes and 
other moulds (23.7, 14.3, and 8.5%) respectively. A 
similar finding is reported in previous studies.9,16,21  
Previously infrequently isolated Candida species are 
now increasingly reported from the different 
geographic regions, indicating a change in the 
epidemiology of Candida species.11 This 
epidemiological variation of Candida species is related 
to a few variables like geological locale, 
immunosuppression, prematurity, experimental utilize 
of the wide range of antimycotics.22 In India and 
Singapore, the C. krusei, C. glabrata, C. parapsilosis, 
and C. tropicalis species were most common. This 
geographic variation is also reported in Malta, Brazil, 
and Mexico.11 Therefore the continuous monitoring of 
onychomycosis pathogens is necessary for the proper 
treatment. 
In this study, the most frequent Candida species were 
Candida albicans (52.68%) being shown in isolates 
followed by Candida non-albicans (47.3%). A similar 
pattern is reported in recent literature.21,23 Among the 
Candida non-albicans, C. tropicalis was the 
predominant species (26.88%) followed by Candida 
parapsilosis (11.82%). The C. glabrata, C. krusei, and 
others were infrequent. A similar prevalence was 
reported in previous studies.16 However, other studies 
reported that C. parapsilosis is the second to C. 
albicans.5,11 The variation of Candida species isolated 
from onychomycosis is well reported.8,24,25 The findings 
in the present study revealed that surveillance is 
necessary for the accurate therapy and changing 




This study revealed that Candida species are the main 
cause of onychomycosis and Candida non-albicans 
species are also increasing in onychomycosis in this 
geographic area. 
408                                                                             Journal of Rawalpindi Medical College (JRMC); 2021; 25(3): 405-408  
References 
 
1. Aghamirian MR, Ghiasian SA. Onychomycosis in Iran: 
epidemiology, causative agents and clinical features. Nippon 
Ishinkin Gakkai Zasshi. 2010; 51(1):23-9.  
2. Lone R, Bashir D, Ahmad S, Syed A, Khurshid S. A study on 
clinico-mycological profile, aetiological agents and diagnosis of 
onychomycosis at a government medical college hospital in 
kashmir. J Clin Diagnos Res. 2013; 7(9):1983. DOI: 
10.7860/JCDR/2013/5969.3378 
3. Del Rosso JQ. The role of topical antifungal therapy for 
onychomycosis and the emergence of newer agents. J Clin Aesth 
Dermatol. 2014; 7(7):10. 
4. Ahmed R, Kharal SA, Durrani MA, Sabir M, Chang AH. 
Frequency of Candida in onychomycosis. J Pak Med Assoc. 2013; 
63(3):350-3. 
5. Otašević S, Barac A, Pekmezovic M, Tasic S, Ignjatović A, 
Momčilović S, Stojanović P, Arsic Arsenijevic V, Hay R. The 
prevalence of Candida onychomycosis in Southeastern Serbia 
from 2011 to 2015. Mycoses. 2016; 59(3):167-72 DOI: 
10.1111/myc.12448. 
6. Eisman S, Sinclair R. Fungal nail infection: diagnosis and 
management. Br Med J. 2014; 348(7953):27-32.  
7. Marais A, Osuch E. Common cutaneous dermatophyte 
infections of the skin and nails. South African Family Practice. 
2017; 59(3):33-40.  
8. Cengiz FP, Cevirgen Cemil B, Emiroglu N, bahalı A, Biyik 
Ozkaya D, Su O, Onsun N. Etiology of onychomycosis in patients, 
Turkey. J Am Pediatr Med Assoc. 2017 Jun 8. DOI: 10.7547/16-
139. Epub 2017 Jun 8 
9. Suryawanshi RS, Wanjare SW, Koticha AH, Mehta PR. 
Onychomycosis: dermatophytes to yeasts: an experience in and 
around Mumbai, Maharashtra, India. Intern J Res Med Sci. 2017; 
5(5):1959-63.  
10. Sav H, Baris A, Turan D, Altinbas R, Sen S. The frequency, 
antifungal susceptibility and enzymatic profiles of Candida 
species in cases of onychomycosis infection. Microbial 
Pathogenesis. 2018; 116:257-62. DOI: 
10.1016/j.micpath.2018.01.036. Epub 2018 Feb 20. 
11. Fich F, Abarzúa-Araya A, Pérez M, Nauhm Y, León E. 
Candida parapsilosis and Candida guillermondii: emerging 
pathogens in nail candidiasis. Indian J Dermatol. 2014; 59(1):24. 
DOI: 10.4103/0019-5154.123485. 
12. Narain U, Bajaj AK. Candida onychomycosis: Indian 
scenario. Intern J Advances Med. 2016; 3(3):638-642.  
13. Mohammadi R, Mirhendi H, Hedayati MT, Badali H. 
Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from 
Onychomycosis in Iran. Iranian J Public Health. 2017; 46(2):235.  
14. Medina IR, Fuentes LR, Arteaga MB, Valcárcel FR, Arbelo FA, 
del Castillo DP, Suárez SD, Quintana OF, Gutiérrez BV, Sergent 
FS, Acosta-Hernández B. Pigeons and their droppings as 
reservoirs of Candida and other zoonotic yeasts. Revista 
Iberoamericana de Micologia. 2017 Oct 1;34(4):211-4. DOI: 
10.1016/j.riam.2017.03.001. 
15. Jayatilake JA, Tilakaratne WM, Panagoda GJ. Candidal 
onychomycosis: a mini-review. Mycopathologia. 2009; 
168(4):165-73. DOI: 10.1007/s11046-009-9212-x. 
16. Bedaiwy MY, Metwally MA, El Zawawy NA, Saba HE. 
Epidemiology, Causative Agents and Clinical Features of 
Onychomycosis in El-Gharbia Governorate. Egyptian J Bot. 2017; 
57:187-196.  
17. Husain MA, Alam MN, Joarder Y, Ferdous M. Correlation 
between clinical and mycological diagnosis of onychomycosis. J 
Pak Assoc Dermatol. 2018; 27(3):220-5. 
18.  Roe JN, Grammer TC, O'Neil MP, inventors; DEVICEFARM 
Inc, assignee. Onychomycosis treatment apparatus and method. 
United States patent application US 10/039,782. 2018. 
19. Afsarian SM, Badali H, Shokohi T, Najafipour S. Molecular 
diversity of Candida albicans isolated from immunocompromised 
patients, based on MLST Method. Iranian J Public Health. 2015; 
44(9):1262. 
20. Malik NA, Raza N. Non-dermatophyte moulds and yeasts as 
causative agents in onychomycosis. J Pak Assoc Dermatol. 2016; 
19(2):74-8. 
21. Soltani M, Khosravi AR, Shokri H, Sharifzadeh A, Balal A. A 
study of onychomycosis in patients attending a dermatology 
center in Tehran, Iran. J de Mycologie Medi. 2015; 25(2):e81-7. 
DOI: 10.1016/j.mycmed.2015.03.007. Epub 2015 May 4. 
22. Deorukhkar SC, Saini S, Mathew S. Non-albicans Candida 
infection: an emerging threat. Interdisciplinary Perspec Infect 
Dis. 2014; 2014. DOI: 10.1155/2014/615958. 
23. Dubljanin E, Džamić A, Vujčić I, Grujičić SŠ, Arsenijević VA, 
Mitrović S, Čalovski IČ. Epidemiology of onychomycosis in 
Serbia: a laboratory‐based survey and risk factor identification. 
Mycoses. 2017; 60(1):25-32. DOI: 10.1111/myc.12537. Epub 
2016 Jul 29. 
24. Pakshir K, Zomorodian K, Zakaei A, Motamedi M, Ghiasi 
MR, Karamitalab M. Molecular identification and in-vitro 
antifungal susceptibility testing of Candida species isolated from 
patients with onychomycosis. Current Med Mycol. 2015; 1(4):26. 
25. Ramudamu M, Lyngdoh WV, Prasad A, Rajbongshi J, 
Durairaj E. A Study On The Mycological Profile Of 
Onychomycosis In A Tertiary Care Hospital In Northeast India. 
Indian J App Res. 2018 Aug 6;8(1):306-309. 
